National survey of patient perspectives on cost discussions.

• DOI: 10.1200/op.2023.19.11_suppl.310
• Publication Date: 2023-10-26T13:03:34Z
• Authors: Anh Lam; Ryan David Nipp; Jill S. Hasler; Bonnie Y Hu; Gregory J Zahner; Sarina Robbins; Stephanie B. Wheeler; Erin K Tagai; Suzanne M. Miller; Jeffrey M. Pepper...
• Keywords: Depression

310 Background: Patients with cancer often experience financial concerns and may seek help from copay assistance programs (CAPs). We sought to describe CAP recipients’ experiences preferences for cost discussions. Methods: From 10-11/2022, we conducted a national, cross-sectional survey of recipients diagnosis or autoimmune condition, which asked about patient perspectives on discussions (desire discuss costs, want doctors consider out pocket [OOP] believe should ensure patients can afford treatment prescribed, report their doctor had discussed costs). used multivariable logistic regression models factors associated explored associations among discussion toxicity (COST tool), depression/anxiety symptoms (PHQ-4), health literacy. Results: Among 1,566 participants, 71% 29% an condition. Of those cancer, hematologic malignancy, 19% metastatic solid tumor, 4% non-metastatic 6% did not disclose type. Although 62% respondents desired discussions, only 32% reported that they took place. Over half (52%) wanted OOP 61% believed prescribed. Those malignancy (OR 0.63, p=.007) Hispanic ethnicity 0.42, p=.020) were less likely desire tumor than condition costs 0.50, p<.001; OR 0.64, p=.040, respectively) 0.56, p=.001; 0.52, p=.004, respectively). 0.59, p=.004), 0.24, p=.009), more comorbidities 0.55, p=.011) having severe 1.79, p<.001) 1.43, p=.017). Depression belief 1.47, p=.038). lower literacy discussing 1.38, p=.021) 1.32, p=.047). Conclusions: In this large sample conditions, most felt while ensuring However, under one third found these outcomes, inform future work regarding patient-clinician concerns.